Today in News History

On July 12, several notable moments in the history of News stand out. In 1488, Joseon Dynasty official Choe Bu returned to Korea after months of shipwrecked travel in China. In 1854, George Eastman, American businessman, founded Eastman Kodak (died 1933) was born. In 1884, Louis B. Mayer, Russian-born American film producer, co-founded Metro-Goldwyn-Mayer (died 1957) was born. In 1895, Buckminster Fuller, American architect and engineer, designed the Montreal Biosphère (died 1983) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. In 2006, The 2006 Lebanon War begins. In 2015, Cheng Siwei, Chinese engineer, economist, and politician (born 1935) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Cross-border biotech deals grow more complex as US targets China investment links

South China Morning Post

South China Morning Post

·

June 21, 2026

·

lean left
Cross-border biotech deals grow more complex as US targets China investment links

Cross-border biotech deals between China and the United States are becoming more complicated and could face a modest slowdown as Washington steps up efforts to restrict investment and technology transfers, according to industry analysts. “There will be more geopolitical scrutiny going forward. This scrutiny may lead to slightly fewer deals than without it,” said Diederik Stadig, senior healthcare economist at ING Research. Despite the growing regulatory hurdles, Stadig said the broader trend of...

Narrative Intelligence Brief

This article was published by South China Morning Post, a source frequently categorized with a lean left bias based in Hong Kong. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of South China Morning Post, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 33%

Center 50%

Right 17%


UrduPoint

lean right

· Jun 27, 2026

Multinational healthcare companies expand R&D and supply chain links in China

Multinational healthcare companies expand R&D and supply chain links in China

BBC News - Business

center

· Jun 29, 2026

South Korea unveils $880bn chip and AI investment plan

It comes as regional rivals like Taiwan, China and Japan are investing heavily in chip factories and other technology.

South China Morning Post

lean left

· Jul 2, 2026

China AI drug-design deals swell as US scrutiny mounts

Riding a wave of booming cross-border dealmaking, China’s AI-driven drug-design firms are charging onto the global stage despite Washington’s growing scrutiny of Chinese biotech firms. The value of out-licensing deals struck by Chinese biotech companies with top global multinational pharmaceutical companies climbed to US75 billion in the first five months of 2026, up from zero before 2020, according to Linda Shu, head of China healthcare research at HSBC. In total, over the five months, these...

CNN

lean left

· Jun 25, 2026

From Shein to Pop Mart: How Chinese brands are grabbing global market share

Chinese companies are moving beyond their home base, expanding overseas and reshaping fashion, tech, and consumer markets worldwide. CNN’s Hanako Montgomery explains why.

The Eastern Herald

center

· Jul 2, 2026

Chinese AI Biotech Licensing Surges to $75 Billion While US Scrutiny Mounts

Chinese biotech firms struck 75 billion in out-licensing deals in the first five months of 2026, an 87 percent year-on-year increase in deal volume. The Metis TechBio and Boulevard Bio deal, worth up to 1.6 billion in milestone payments, shows the market moving faster than US regulators.

BRICS News

center

· Jun 22, 2026

[Photo] JUST IN: 🇨🇳🇺🇸 China imposes sanctions on several American companies in retaliation for [...]

JUST IN: China imposes sanctions on several American companies in retaliation for US restrictions on Chinese tech firms.@BRICSNews

Topics:

World · 4
Business · 1
Politics · 1

Related coverage for "Cross-border biotech deals grow more complex as US targets China investment links": UrduPoint — Multinational healthcare companies expand R&D and supply chain links in China. BBC News - Business — South Korea unveils $880bn chip and AI investment plan. South China Morning Post — China AI drug-design deals swell as US scrutiny mounts. CNN — From Shein to Pop Mart: How Chinese brands are grabbing global market share. The Eastern Herald — Chinese AI Biotech Licensing Surges to $75 Billion While US Scrutiny Mounts. BRICS News — [Photo] JUST IN: 🇨🇳🇺🇸 China imposes sanctions on several American companies in retaliation for [...]